Ketamine Dosing and Monitoring
Educational resources on dosing concepts, titration conversations, pharmacokinetics, tolerance, route differences, and treatment-response tracking.
Do not self-dose
Dosing articles explain clinical concepts and must not replace individualized prescribing instructions.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Featured
3 articles
Ketamine Bioavailability by Route: A Patient Comparison
How sublingual, oral, intranasal, IM, and IV ketamine compare on bioavailability and why route shapes both dose and effect. A patient-friendly low-dose framing.
Ketamine Troche Dosage: A Patient Reference Guide
Typical sublingual ketamine troche dosage ranges, how lozenges are dosed for depression and maintenance, what to know about increments, and key safety considerations.
PHQ-9 and GAD-7 in Ketamine Dose Adjustment: A Patient Guide
Learn how PHQ-9 and GAD-7 assessments guide ketamine dose adjustments. Patient-focused guide to understanding symptom tracking and dosing decisions.
Ketamine Bioavailability by Route: A Patient Comparison
How sublingual, oral, intranasal, IM, and IV ketamine compare on bioavailability and why route shapes both dose and effect. A patient-friendly low-dose framing.
Ketamine Troche Dosage: A Patient Reference Guide
Typical sublingual ketamine troche dosage ranges, how lozenges are dosed for depression and maintenance, what to know about increments, and key safety considerations.
PHQ-9 and GAD-7 in Ketamine Dose Adjustment: A Patient Guide
Learn how PHQ-9 and GAD-7 assessments guide ketamine dose adjustments. Patient-focused guide to understanding symptom tracking and dosing decisions.
Tracking Treatment Response to Ketamine: PHQ-9, MADRS, and Clinical Scales
A clinician's guide to systematic outcome measurement in ketamine therapy, covering validated rating scales, assessment frequency, response and remission thresholds, and data-driven decision-making for dosing adjustments.
What Is Ketamine's Half-Life?
How long does ketamine stay active? A look at the 2-3 hour plasma half-life, norketamine metabolism, and why antidepressant effects outlast the drug itself.
How Many Ketamine Treatments Are Needed?
How many ketamine sessions does a typical course take? Review of 6-infusion induction, maintenance scheduling, and response data on course length.
What Is the Standard Ketamine Dose for Depression?
What is the standard ketamine dose for depression? 0.5 mg/kg IV over 40 minutes, plus how oral and sublingual low-dose protocols translate from that baseline.
Ketamine Tolerance: Understanding Dose Adjustments Over Time
Do patients build tolerance to ketamine? A clinical review of tolerance mechanisms, clinical signs, and evidence on adjusting dose over repeated treatment.
Pediatric Low-Dose Ketamine: Dosing Considerations and Safety
Review of pediatric low-dose ketamine dosing considerations, covering developmental pharmacokinetics, age-specific safety data, and clinical applications in children and adolescents.
Esketamine vs Racemic Ketamine Dosing: Comparative Pharmacology
How do esketamine and racemic ketamine doses compare? Review of enantiomer pharmacology, potency differences, route-specific dosing, and clinical equivalencies.
Optimizing Oral Ketamine Bioavailability: Pharmacokinetic Strategies
How is oral ketamine bioavailability improved? Review of sublingual delivery, formulation choices, metabolic inhibition, and low-dose implications.
Weight-Based Dosing Guidelines for Low-Dose Ketamine
Practical guidance on weight-based dosing calculations for low-dose ketamine across clinical indications. Addresses ideal versus actual body weight considerations, dosing ranges by route and indication, and special population adjustments.
Pharmacokinetics of Ketamine: Absorption, Distribution, Metabolism, and Elimination
A comprehensive overview of ketamine pharmacokinetics across all clinically relevant routes of administration. Covers bioavailability, volume of distribution, hepatic metabolism via CYP enzymes, half-life considerations, and the role of active metabolites.
Renal and Hepatic Dose Adjustments for Low-Dose Ketamine
How is low-dose ketamine adjusted for kidney or liver impairment? Review of pharmacokinetic rationale, dose modification, and monitoring in at-risk patients.
Defining Sub-Anesthetic Ketamine: Dose Ranges and Therapeutic Windows
Comprehensive guide to sub-anesthetic ketamine dose ranges and therapeutic windows, covering pharmacological thresholds, receptor occupancy, and clinical dose-response relationships.
Dose-Response Relationships in Low-Dose Ketamine Therapy
An in-depth examination of ketamine dose-response curves across indications including depression, chronic pain, and procedural analgesia. Covers threshold doses, ceiling effects, and how response varies with clinical context.